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Organisms evolve two routes to surviving infections—they can resist pathogen growth (resistance) and they can
endure the pathogenesis of infection (tolerance). The sum of these two properties together defines the defensive
capabilities of the host. Typically, studies of animal defenses focus on either understanding resistance or, to a lesser
extent, tolerance mechanisms, thus providing little understanding of the relationship between these two mechanisms.
We suggest there are nine possible pairwise permutations of these traits, assuming they can increase, decrease, or
remain unchanged in an independent manner. Here we show that by making a single mutation in the gene encoding a
protease, CG3066, active in the melanization cascade in Drosophila melanogaster, we observe the full spectrum of
changes; these mutant flies show increases and decreases in their resistance and tolerance properties when challenged
with a variety of pathogens. This result implicates melanization in fighting microbial infections and shows that an
immune response can affect both resistance and tolerance to infections in microbe-dependent ways. The fly is often
described as having an unsophisticated and stereotypical immune response where single mutations cause simple
binary changes in immunity. We report a level of complexity in the fly’s immune response that has strong ecological
implications. We suggest that immune responses are highly tuned by evolution, since selection for defenses that alter
resistance against one pathogen may change both resistance and tolerance to other pathogens.
Citation: Ayres JS, Schneider DS (2008) A signaling protease required for melanization in Drosophila affects resistance and tolerance of infections. PLoS Biol 6(12): e305.
doi:10.1371/journal.pbio.0060305
Introduction
Evolutionary theory suggests that a host can protect itself
against an infectious pathological threat by evolving two
different mechanisms to increase ﬁtness or health. The ﬁrst is
to reduce the ﬁtness of the pathogen, thereby reducing the
number of pathogens attacking the host. The second is to
limit the health costs to the host. The sum of both these
mechanisms deﬁnes an individual host’s defensive capabil-
ities. In the plant ecology community, these two mechanisms
are deﬁned as resistance and tolerance [1–5]. Dividing the
physiological response to infections into these two compo-
nents is important because it demonstrates that the health of
a host cannot be measured solely by its ability to survive an
infection and that studying both pathogen clearance and
pathology is essential to fully understanding the defensive
measures of a host. Typically in animal immunity studies we
focus on understanding resistance mechanisms. For example,
most work on Drosophila immunity to date has concentrated
on pattern recognition pathways that, when mutated, permit
overgrowth of bacteria and thus reduce host defenses [6–12].
There is evidence that tolerance properties exist in Drosophila,
but the relationship between these mechanisms and resist-
ance mechanisms, as well as their effects on host defense, have
not been examined [13–17].
Tolerance as deﬁned by the evolutionary community
measures the slope of ﬁtness versus pathogen load [18–20].
These parameters are quite difﬁcult to assay in Drosophila
infections; in the ﬂy, morbidity is most easily measured by
measuring the mean time to death and therefore we do not,
strictly speaking, assay ﬁtness. In addition, it is difﬁcult to
measure the number of infecting bacteria in a ﬂy without
killing the ﬂy, and thus we cannot easily relate the bacterial
number in a given ﬂy with mortality because both assays are
destructive. We deﬁne tolerance in the ﬂy system by stating
that a ﬂy that can survive a given level of microbes better than
another ﬂy is better able to tolerate an infection.
Changes in tolerance and resistance could have compli-
cated effects on host defenses. We predict that for any given
mutation, there are nine qualitatively different potential ways
of affecting resistance and tolerance of a host, though the
actual number of states is inﬁnite (Figure 1). We imagine that
both properties could be enhanced, diminished, or left
unchanged by a single mutation. In our ﬂy infection system
not all nine of these combinations will be readily distinguish-
able. We inject ﬂies with a pathogen and then monitor host
survival and bacterial growth. Changes in resistance in
mutants are detected by measuring pathogen growth and
comparing these levels to those observed in infected wild-
type ﬂies. Tolerance of mutant ﬂies is measured functionally
as a change in survival when pathogen levels resemble that of
infected wild-type ﬂies. This mode of measurement prevents
Academic Editor: Daniel Promislow, University of Georgia, United States of
America
Received July 28, 2008; Accepted October 28, 2008; Published December 9, 2008
Copyright:  2008 Ayres and Schneider. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Abbreviations: PPO, prophenoloxidase
* To whom correspondence should be addressed. E-mail: dschneider@stanford.edu
PLoS Biology | www.plosbiology.org December 2008 | Volume 6 | Issue 12 | e305 2764
PLoS BIOLOGYus from measuring changes in tolerance when microbe levels
are also changing. Therefore, we predict that we should be
able to differentiate among only ﬁve of these nine classes
unless there are special circumstances, as described below.
To test this prediction we examined the effects of altering
the melanization arm of the Drosophila immune response on
ﬂy defense to a variety of pathogens. We chose this immune
response because we anticipated that it not only functioned
as a resistance mechanism in the ﬂy and directly ﬁghts
infections but could also cause considerable pathology in the
host because it generates reactive oxygen; we expected this
pathology would lead to changes in tolerance. Melanization
is a presumed immune mechanism in the ﬂy that produces
melanin, visible as dark brown deposits, at the site of wounds
and infection. Melanin is deposited after a chain of events
induced by pattern recognition proteins, propagated by
serine proteases and ultimately produced by the enzyme
phenoloxidase [21–23]. In Drosophila,o n es u c hs e r i n e
protease is CG3066, which acts in a melanization cascade
that is negatively regulated by the serpin Spn27A [24,25].
Conventional wisdom suggests that melanin can sequester
microbes to prevent their spread and that reactive oxygen
species generated during melanin production can be
directly harmful to microbes and possibly the host. There
is evidence from work in other invertebrates, such as the
crayﬁsh Pacifastacus leniusculus, demonstrating that PPO
activity is important for limiting microbial virulence [26–
29]; however, the available literature concludes that melani-
zation in Drosophila plays no role in ﬁghting microbial
infections, or it plays a redundant role, at best [24,25,30].
Though quite well deﬁned biochemically, the functional
contribution of this potential effector pathway to immunity
remains in dispute.
In the present study we show that by making a single
mutation in the melanization arm, speciﬁcally CG3066, of the
ﬂy innate immune response, we could alter both tolerance
and resistance in a microbe dependent fashion. By doing so
we observed ﬁve of the nine predicted phenotypic classes for
changes in resistance and tolerance. Among these ﬁve we
found two cryptic phenotypes in which there was no change
in survival of the mutant ﬂies but bacterial levels were very
different from those found in wild-type ﬂies. This suggests
that resistance and tolerance had achieved a new balance in
these ﬂies. We also found an unanticipated phenotype of
CG3066 ﬂies; these ﬂies die signiﬁcantly faster than wild-type
ﬂies when injected with sterile medium. We suggest that, in
addition to its effects on the outcome of infections, this
protease is important for tolerating some of the pathology
that occurs during wounding. Typically in ﬂy immunity,
mutations have been reported to produce only two pheno-
typic classes—the ﬂies either become sensitive to infections
or their phenotype is unchanged. This work shows a level of
complexity that has been missing in the description of
Drosophila immunity. We suggest that these results have
important implications about the evolution of immunity
and that the equilibrium between resistance and tolerance of
a host will be optimized by its interactions with pathogens in
the wild.
Figure 1. Manipulation of Resistance and Tolerance Affects Host Health
We hypothesize that resistance and tolerance of a host can be
manipulated in an independent manner, generating nine possible
pairwise permutations to affect overall host health. Mutant phenotypes
can be mapped onto a two-dimensional space where the axes are
defined by health and pathogen load. We measure median survival time
as a proxy for health and measure bacterial load directly in homogenized
flies. The red dot represents the phenotype of a wild-type fly strain
infected with a pathogen. Any given mutation could either have no
effect or shift the phenotype to any of the eight red dots. Theoretically,
phenotypic shifts can occur by altering either the resistance of the host,
the tolerance, or both properties. The areas marked in blue show the
area where shifts in resistance are expected to move the phenotypes; the
pale yellow bar indicates the areas affected by shifts in tolerance, and the
green shows areas that are caused by changes in both properties.
doi:10.1371/journal.pbio.0060305.g001
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A Mutant Links Resistance and Tolerance
Author Summary
To boost its defenses, an organism may increase its resistance to
infection by reducing the fitness of the invading pathogen;
alternatively, the host may increase its tolerance by reducing the
damage caused by a given quantity of pathogen. Melanization is an
immune response that has been linked to defense in the fly and
other invertebrates. It is expected to cause resistance to infection, as
well as host damage mediated by reactive oxygen species
generated during melanin production. We demonstrate here that
the loss of a gene required for melanization produces a surprisingly
complex spectrum of phenotypes, increasing and decreasing both
resistance and tolerance to a variety of microbes. For example,
increasing resistance to one pathogen can produce corresponding
changes in either resistance or tolerance to another pathogen. As a
result, there is likely no ‘‘best’’ solution that produces a perfect
immune system, only an equilibrium that allows the fly to deal with
the pathogenic threats that its ancestors have faced. This
equilibrium will require the balancing of both resistance and
tolerance, and our study demonstrates that we cannot completely
understand the defensive properties of a host unless we measure
both of these properties in response to a variety of pathogens.Results
Some Bacterial Infections Elicit a Disseminated
Melanization Response in the Fly
Previous studies examining the contribution of melaniza-
tion to ﬂy immunity did not test microbes that induce large
melanization responses in the ﬂy. Tang et al. observed that
ﬂies pierced with a needle containing a mixture of E. coli and
Micrococcus luteus caused melanization at the site of needle
insertion and concluded that this response was speciﬁc to the
infection [25]. Although it is possible that the melanization
observed was triggered by the infection, this cannot be
concluded with conﬁdence because injection with a sterile
needle also results in deposits of melanin at the site of
wounding approximately 24 h postinjection. Leclerc et al. did
not report observations of melanization [24]. In Listeria
monocytogenes– and Salmonella typhimurium–infected ﬂies we
observed, in addition to melanization at the site of injection,
deposits of melanin just underneath the cuticle as well as in
deeper tissues. This melanization is easily seen approximately
4d( L. monocytogenes)o r7d( S. typhimurium) after infection
(Figure 2; unpublished data). We refer to this as a
disseminated melanization response. We were curious if
other bacteria elicited disseminated melanization during
infection. We selected a diverse panel of bacteria and
compared the patterns of melanization observed with
media-injected control ﬂies (Table 1).
Within the ﬁrst 24 h postinfection, we saw melanin at the
site of injection that was comparable to what we observed in
ﬂies that received a control injection of media. This was true
for all bacteria tested. In addition to the melanization at the
injection site, we found that L. monocytogenes, S. typhimurium,
and Staphylococcus aureus all elicit a robust disseminated
melanization response in infected ﬂies. On average we found
that more than 90% of females and more than 70% of males
infected with L. monocytogenes exhibit disseminated melaniza-
tion, and the majority of these ﬂies have spots of melanin
deposited along the dorsal and ventral sides of the abdomen
(Figures 2 and 3). These deposits can be found on the cuticle
of both sexes, and large melanin clots are commonly observed
within the ovaries of females. To a lesser extent we also ﬁnd
melanization along the thorax and the head. In S. typhimu-
rium–infected ﬂies, on average, more than 80% of females and
70% of males exhibit a disseminated melanization response
over the course of the infection, and we observe similar
patterns of melanization to what we see with L. monocytogenes.
The majority of ﬂies exhibit melanization in the abdomen on
the cuticle and also in the ovaries of females (Figure 2). In
contrast to L. monocytogenes infections, we did not see
melanization in the thorax or the head segments with S.
Figure 2. Disseminated Melanization in Infected Flies
Ventral, dorsal, and injection site views of the abdomen of L. monocytogenes– or medium-injected female w
1118 and CG3066 mutants. Deposits of melanin
at the injection site (green arrows) can be seen in both wild-type and mutant flies for both microbe and medium injections. No melanin is observed on
either fly strain beyond what is seen at the injection site in the absence of infection. Large amounts of melanin are deposited on both the ventral and dorsal
sides of the abdomen in wild-type flies when infected with L. monocytogenes, while no melanin is observed in L. monocytogenes-infected CG3066 mutants.
doi:10.1371/journal.pbio.0060305.g002
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A Mutant Links Resistance and Tolerancetyphimurium. S. aureus–infected ﬂies exhibit a different pattern
of melanization; we found approximately 40%–50% of both
infected females and males exhibit a punctuate patterning of
melanin deposits localized to the dorsal vessel. On occasion
there are large melanized particles deeper in the tissue of the
abdomen. No melanin is deposited along the thorax or the
head. We did not observe melanization beyond that seen at
the injection site in ﬂies infected with the remaining bacteria
tested: Enterococcus faecalis, Streptococcus pneumoniae, Escherichia
coli, and Burkholderia cepacia (Figure 3).
Absence of Phenol Oxidase Activation Alters Drosophila
Resistance and Tolerance Properties
Once we identiﬁed bacteria that elicit a disseminated
melanization response we wanted to test whether this
melanization response was important for a ﬂy’s survival and
how this response affects resistance and tolerance during an
infection. There are three genes encoding phenoloxidases in
the ﬂy, monophenoloxidase (Bc), diphenol oxidase a2, and
diphenol oxidase a3 [31]. The Bc gene has received the most
attention for its involvement in immunity because of its
Figure 3. Quantification of Disseminated Melanization in Infected Flies
Male and female 5- to 7-d-old w
1118 and CG3066 mutants were infected with the microbes listed in Table 1 or with medium and examined for
disseminated melanization throughout the course of infections with L. monocytogenes, S. typhimurium, S. aureus, E. faecalis, S. pneumoniae, E. coli, and B.
cepacia. Melanization can be observed in L. monocytogenes-infected flies approximately 4 d postinfection, while melanization in S. typhimurium and S.
aureus-infected flies can be seen approximately 7 d postinfection. Values indicate the percentage of infected wild-type or CG3066 mutants that exhibit
disseminated melanization, and data are represented as mean 6 standard error of the mean. At least three groups of 20 flies were examined for each
condition, and experiments were repeated three times and yielded similar results.
doi:10.1371/journal.pbio.0060305.g003
Table 1. Microbial Strain List
Microbe Strain Class Infection Toll Mutant Phenotype imd Mutant Phenotype Melanization Phenotype
B. cepacia ATCC25416 Gram negative Extracellular Not sensitive Sensitive Nonmelanizer
E. coli DH5a Gram negative Extracellular Not sensitive Sensitive Nonmelanizer
E. faecalis V583 Gram positive Extracellular Sensitive Sensitive Nonmelanizer
L. monocytogenes 10403S Gram positive Intracellular Sensitive Sensitive Melanizer
S. aureus Clinical isolate Gram positive Extracellular Sensitive Sensitive Melanizer
S. pneumoniae SP1 Gram positive Extracellular Sensitive Sensitive Nonmelanizer
S. typhimurium SL1344 Gram negative Intracellular Not sensitive Sensitive Melanizer
The strain, class, and type of infection for each microbe tested are listed here. Melanization phenotypes and the survival phenotypes of Toll and imd mutants for each infection are also
listed. A ‘‘melanizer’’ phenotype indicates that the microbe elicits a disseminated melanization response; ‘‘nonmelanizer’’ indicates that there is no melanization beyond what is observed
at the site of injection. A ‘‘sensitive’’ phenotype indicates that the mutant flies die faster compared to wild-type flies infected with the same microbe. A ‘‘not sensitive’’ phenotype
indicates that there is no significant difference between the death rate of the mutant and that of wild-type flies.
doi:10.1371/journal.pbio.0060305.t001
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A Mutant Links Resistance and Tolerancesingle characterized mutant, which eliminates circulating
phenoloxidase from the hemolymph [32–34]. This allele Bc
1 is
assumed to map to the monophenol oxidase gene; however,
its molecular nature has not been reported [35]. Bc
1 is a
dominant mutation that appears to prematurely activate
phenoloxidase in larval crystal cells. A troubling aspect of this
mutation is that it damages crystal cells and causes them to be
phagocytosed by plasmatocytes, and the melanized remains of
these cells sit undigested in the hemocytes for the life of the
ﬂy [36]. We anticipated that this Bc mutation could have
pleiotropic effects on the immune response; it blocks
phenoloxidase activity, but it is also anticipated to alter the
cellular immune response because it destroys one immune
cell outright and causes another to be ﬁlled with undigestible
material. Since the cellular immune response plays an
important role in ﬁghting many infections, we sought another
way to reduce melanization.
Leclerc et al. identiﬁed the protease encoded by CG3066 as
a prophenoloxidase activating enzyme (PPO), whereas Tang
et al. reported that CG3066 enzyme was required for PPO
activation but did not directly target PPO. A mutation of this
gene was reported to inhibit the immune induced proteolytic
cleavage of a Drosophila protein that cross-reacted with a
mosquito anti-phenoloxidase antibody [24]. RNAi inhibition
of this gene blocked the induction of phenoloxidase activity
in ﬂy extracts [25]. Thus CG3066 mutants appeared to be a
useful tool for dissecting the role melanization might play in
resistance and tolerance. We found that these mutants are
capable of producing melanin deposits at the site of injection
for both media and microbial challenges comparable to that
observed in wild-type ﬂies (Figure 2); however, we did not
observe a disseminated response in the CG3066 mutants with
L. monocytogenes, S. typhimurium, S. aureus, or any of the other
bacteria tested (Figures 2 and 3).
To determine how CG3066 affects both tolerance and
resistance properties of Drosophila we challenged CG3066
mutant ﬂies with our panel of bacteria and measured survival
rates and bacterial loads (Figures 4 and 5). The microbes we
tested produced infections that fell into ﬁve different
phenotypic classes.
The ﬁrst class includes L. monocytogenes and S. typhimurium.
These microbes killed CG3066 mutants faster than wild-type
Figure 4. Survival of Infected CG3066 Mutants
Male 5- to 7-d-old flies were infected with bacteria or medium and survival was recorded daily for B. cepacia; E. coli; E. faecalis; L. monocytogenes
infection in CG3066
K02818 mutant (p , 0.0001); L. monocytogenes infection in UAS-CG3066 RNAi (p , 0.0001); S. aureus (p , 0.0001) and S. pneumoniae
(p , 0.0001) with medium control; S. pneumoniae without medium control (p , 0.0001); S. typhimurium (p , 0.0001) and medium versus
unmanipulated flies (p , 0.0001). Filled squares represent microbe-injected wild-type flies, filled circles indicate microbe-injected CG3066 mutant flies,
open squares/dashed lines represent medium-injected wild-type flies, open circles/dashed lines indicate medium-injected CG3066 mutants,3indicates
unmanipulated wild-type flies, and asterisks (*) indicate unmanipulated CG3066 mutants. For RNAi experiments expression was driven by the collagen-
GAL4 driver, Cg-GAL4. Squares represent wild-type flies, circles represent Cg-GAL4/UAS-CG3066 RNAi, triangles represent Cg-GAL4/wild type, and
diamonds represent UAS-CG3066 RNAi/wild type. Data are plotted as Kaplan-Meier plots and statistical significance was determined using log-rank
analysis. Survival curves were repeated at least three times and yielded similar results each time.
doi:10.1371/journal.pbio.0060305.g004
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A Mutant Links Resistance and Toleranceﬂies and showed increased bacterial growth rates. S. typhimu-
rium–infected mutants exhibited a 60% reduction in the
median time to death (p , 0.0001) with respect to wild-type
ﬂies, and there was a 50% reduction in survival in L.
monocytogenes–infected ﬂies (p , 0.0001) (Figure 4). Using the
UAS-GAL4 system and transgenic ﬂies expressing double-
stranded RNA targeting CG3066, we conﬁrmed this reduction
in survival by RNAi (p , 0.0001) (Figure 4). S. typhimurium and
L. monocytogenes grew to signiﬁcantly higher levels at both 24
and 48 h postinfection in CG3066 mutants as compared to
isogenic, wild-type parental controls (for both L. monocytogenes
and S. typhimurium at 24 h p , 0.05, for both L. monocytogenes
and S. typhimurium at 48 h p , 0.005) (Figure 5). This
demonstrates that CG3066 plays an important and primary
role in ﬁghting some bacterial infections in the ﬂy.
L. monocytogenes establishes an intracellular infection in
wild-type Drosophila. We performed a gentamicin chase
experiment to determine the location of the L. monocytogenes
in mutant ﬂies. Following infection, ﬂies were injected with
gentamicin, which will kill extracellular bacteria, while
intracellular bacteria are protected from the antibiotic [16].
Control ﬂies were injected with medium. Following a 3-h
chase, ﬂies were homogenized and plated to determine
bacteria levels. This allowed us to measure the numbers of
both intracellular and extracellular bacteria in the ﬂy and to
determine the contribution this protease might have on both
populations of bacteria. We found signiﬁcantly more bacteria
in the CG3066 mutant ﬂies that received the medium chase
compared to those that received the gentamicin chase,
suggesting that there is an extracellular population of L.
monocytogenes present in these mutants that is not present in
wild-type ﬂies (24 h, p ¼ 0.0022; 48 h, p ¼ 0.0043) (Figure 5).
Similarly, we found an increase in L. monocytogenes growth
when CG3066 expression is knocked down using RNAi
(Figure 5). We conclude that CG3066 is normally important
in controlling the growth of these microbes by enhancing the
Figure 5. Bacterial Growth in CG3066 Mutants
Bacterial growth was determined for B. cepacia; E. coli; E. faecelis; L. monocytogenes growth in CG3066
K02818 mutants; L. monocytogenes growth in UAS-
CG3066 RNAi; and E. coli, and S. pneumoniae. Male 5- to 7-d-old flies were infected with bacteria and collected at 0, 24, and 48 h postinfection. S.
pneumoniae–infected flies were collected at 0, 2, 4, and 24 h postinfection. Flies were homogenized at each time point, serially diluted, and plated. For L.
monocytogenes infection, flies were injected with 50 nl of 1 mg/ml gentamicin or water 3 h prior to plating. For B. cepacia, E. coli, S. pneumoniae, and S.
typhimurium, solid black boxes indicate wild type, and solid white boxes indicate CG3066 mutant. For gentamicin chase of L. monocytogenes-infected
CG3066 mutants, solid black boxes indicate water-treated wild-type flies, solid white boxes indicate water-treated CG3066 mutants, left diagonal hashed
boxes indicate gentamicin-treated wild-type flies, and right diagonal hashed boxes indicate gentamicin-treated CG3066 mutants. For L. monocytogenes
infection in RNAi flies, solid black boxes indicate wild-type flies, solid white boxes indicate Cg-GAL4/UAS-CG3066 RNAi, horizontal hashed boxes indicate
Cg-GAL4/wild type, and vertical lined boxes indicate UAS-CG3066 RNAi/wild type. The p-value was determined with a nonparametric two-tailed t-test.
Experiments for each microbe were repeated at least three times and gave similar results. * p , 0.01; ** p , 0.005.
doi:10.1371/journal.pbio.0060305.g005
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A Mutant Links Resistance and Toleranceresistance properties of the ﬂy, and this is similar to the sort
of phenotype that has been seen for most Drosophila immunity
mutants.
The second class of microbes we found is deﬁned by E. coli,
which is a nonmelanizer and showed no change in killing
rates or bacterial levels in CG3066 mutants. We deﬁne
pathogenic bacteria as those that cause disease in wild-type
ﬂies; using this criterion, E. coli was the only nonpathogenic
microbe we tested. An E. coli infection does not kill wild-type
ﬂies any faster than control ﬂies injected with medium. We
saw the same result in CG3066 homozygous mutant ﬂies; E. coli
infected mutants die at the same rate as medium injected
mutants (Figure 4). Colony counts in infected CG3066 mutant
ﬂies were the same as seen in wild-type ﬂies with an E. coli
infection (Figure 5). This indicates that CG3066 has no effects
on either ﬂy resistance or tolerance with this type of
infection.
S. pneumoniae deﬁnes our third class of microbes; CG3066
mutants die signiﬁcantly slower when infected with S.
pneumoniae compared to wild-type ﬂies. The median time to
death in CG3066 mutants was extended by 100% (p , 0.0001)
(Figure 4). This increase in survival could have been due to
changes in either resistance or tolerance. If resistance was
altered, we anticipated that there would be differences in the
levels of S. pneumoniae in the mutant ﬂies, while changes in
tolerance would leave the bacterial levels constant. We found
that S. pneumoniae grew at a slower rate in CG3066 mutants
than in wild-type ﬂies, leading us to conclude that CG3066
mutant ﬂies have better resistance against S. pneumoniae
infection when melanization is absent. Alternatively, the
presence of a functional melanization response could actually
promote an S. pneumoniae infection in some manner. These
results were surprising because we anticipated that the
removal of a resistance response might increase the tolerance
of the ﬂy, but did not anticipate that it would increase the
resistance of the host.
The fourth and ﬁfth classes are cryptic and are deﬁned by
E. faecalis and B. cepacia, respectively. Our results with E. faecalis
were in some ways similar to what has been published
previously; we found that E. faecalis killed wild-type and
CG3066 mutant ﬂies at the same rate. This result led Leclerc
et al. to the conclusion that this mutation has no net effect on
immunity [24]; however, we found that colony counts of the
infected ﬂies demonstrated that the story is more compli-
cated than survival rates alone would lead us to believe.
Infected CG3066 mutant ﬂies had signiﬁcantly lower levels of
E. faecalis than do wild-type ﬂies at 48 h postinfection (Figure
5). This result suggests that the resistance properties of these
ﬂies are increased with respect to E. faecalis because the ﬂy is
better able to kill this type of bacteria. Given that the survival
rates of these ﬂies is the same as that of wild-type ﬂies, this
increase in resistance properties appears to be balanced by a
reduction in tolerance. We conclude that a lower number of
E. faecalis can cause disease symptoms in CG3066 ﬂies.
In contrast to what we observed during E. faecalis infections,
we found that although B. cepacia kills wild-type and CG3066
mutant ﬂies at the same rate, there is increased growth of B.
cepacia in the mutant ﬂies. B. cepacia–infected ﬂies exhibit a
median time to death of 5 d post-infection (Figure 4). By 48 h
postinfection, we ﬁnd there is approximately 25 times more
bacteria in the mutant ﬂies compared to wild-type ﬂies (p ¼
0.0043) (Figure 5). This increased bacterial growth suggests
that the resistance mechanisms in the mutant ﬂies are less
effective at ﬁghting a B. cepacia infection. Because this
increased bacterial growth is coupled with no change in
survival we suggest that the decrease in resistance properties
is accompanied by an increase in tolerance, which is the
opposite of what we see with an E. faecalis infection. These E.
faecalis and B. cepacia experiments highlight the importance of
using multiple tests for immunity when studying infections; if
we had assayed survival alone we would have been led to the
conclusion that CG3066 plays no role in the ﬂy’s interactions
with these microbes, when in fact, the gene plays a
complicated role in defense.
The last microbe we tested was S. aureus. S. aureus infected
CG3066 mutants exhibited the most striking difference in
survival with approximately an 80% reduction in the mean
time to death (p , 0.0001) (Figure 4). Our results with S. aureus
differ from those reported by Leclerc et al. who reported no
difference in survival between S. aureus–infected CG3066
mutants and wild-type ﬂies [24]. We did not measure growth
in S. aureus–infected ﬂies because S. aureus aggregates when
grown in ﬂies and this creates a lot of scatter in colony count
experiments [15]. We are therefore unable to determine
whether CG3066 mutants die from a S. aureus infection
because of defects in resistance and/or tolerance properties
and cannot place it in one of our predicted classes.
CG3066 Affects the Response to Wounding
We noted that medium-injected CG3066 mutant ﬂies died
faster than similarly treated wild-type ﬂies. This result was
missed in past publications because the survival curves were
not extended until these control ﬂies died, or these controls
were apparently not performed [25,26]. To determine
whether this was an effect of wounding on survival of
CG3066 mutants or whether these mutant ﬂies were merely
shorter lived, we performed lifespan analysis on unmanipu-
lated mutant and wild-type ﬂies. We found that the
unmanipulated ﬂies had similar life spans (Figure 4). This
suggests that CG3066 is important for tolerating some of the
pathology of the wounding response.
Discussion
By testing a panel of bacteria that cause different types of
infections, we demonstrated that melanization is activated
during infection, and that the degree of activation is
dependent on the type of infection. We predict that there
are nine potential ways of affecting resistance and tolerance
of a host (Figure 1). We found that by mutating a single gene
we could alter both the resistance and tolerance properties of
the ﬂy and observed up to ﬁve of the nine predicted
phenotypic classes. Though not all nine possible classes were
seen, we did observe the four major changes that we
predicted; both tolerance and resistance could be increased
or decreased by a single mutation, and these properties were
dependent upon the particular microbial challenge.
The phenotypes found in CG3066 mutant ﬂies were
somewhat surprising. We anticipated that this protease
mutant would be less able to kill some bacteria and thus
would show decreased resistance. Likewise we predicted that
melanization might cause collateral damage and nonmelaniz-
ing ﬂies would show increased tolerance. It was a surprise to
ﬁnd that melanizing mutants are more resistant to some
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damage done by the reactive oxygen because of autoimmune
damage to the host; or perhaps when ﬂies lack melanization,
other, more effective immune responses show increased
activity. It was also a surprise that tolerance would decrease
in nonmelanizing ﬂies. We propose that regulation could
increase the activity of alternate immunity pathways that
cause increased collateral damage or that the bacteria cause a
different type of pathology in nonmelanizing ﬂies that is
more damaging to the host than we see in wild-type ﬂies.
Of the nine proposed phenotypic classes (Figure 6), three
should be easy to distinguish; these are cases in which
resistance remains unchanged (and thus microbe levels are
the same as in wild-type ﬂies) and tolerance varies (Figure 6,
right). We saw one of these classes: CG3066 mutant ﬂies
infected with E. coli show no change in either resistance or
tolerance. We interpret this as meaning that CG3066 has no
effect at all on this type of infection. We did not see an
example of the second or third class of mutant with our panel
of bacteria. The second class would show no change in
resistance but an increase in tolerance. The third would have
no resistance effect and would reduce tolerance. We note that
we have previously identiﬁed mutations in the second and
third class. We have reported that the ﬂy tumor necrosis
factor–related molecule, eiger, is important for ﬁghting
infections with extracellular pathogens, and eiger mutants
have decreased resistance during these types of infections.
Yet during Salmonella infection we found that eiger mutants
exhibit similar bacterial burdens to wild-type ﬂies but have an
extended life span, indicating that during this type of
infection there is an increase in tolerance with no change
in resistance. Eiger mutants have a balanced increase in
resistance and a decrease in tolerance during a Listeria
infection, similarly to what is seen in CG3066 mutant ﬂies
infected with E. faecalis. Eiger does not appear to exhibit as
many phenotypic combinations of resistance and tolerance as
we observe with CG3066 but it offers additional support that
a single gene can affect both resistance and tolerance in
various ways depending on the microbe [15,16]. In a
published genetic screen we identiﬁed six mutants, all of
which were sensitive to Listeria but exhibited levels of bacteria
comparable to that found in wild-type ﬂies [17]. These six
mutants represent an additional phenotypic class, a decrease
in tolerance with no change in resistance. It is not known if
these genes can affect resistance and tolerance in additional
ways with different types of infections.
Three classes of phenotypes will show a decrease in
resistance (Figure 6, middle). This is the phenotype we
observed with L. monocytogenes and S. typhimurium infections.
These bacteria grow faster in CG3066 mutants and the ﬂies
die faster. Typically, we cannot distinguish changes in
tolerance here because we do not have a good method of
keeping the bacterial levels constant or correlating bacterial
load and morbidity. B. cepacia provides a special case where
CG3066 mutant ﬂies show no change in survival but show a
signiﬁcant increase in bacterial load when infected with this
bacterium. This suggests that there must be a balanced
change in resistance and tolerance in these ﬂies.
Because we did not determine the growth of S. aureus in
CG3066 mutants, we cannot determine whether resistance
and/or tolerance is affected with this microbe. If we were to
consider the survival and melanization phenotypes in S.
aureus-infected CG3066 mutants only, we would suggest that it
falls into the same class as L. monocytogenes and S. typhimurium.
Yet, because we have seen that survival is not an accurate
predicator of bacterial loads we cannot make this claim.
Another three classes of phenotypes are expected to show
an increase in resistance (Figure 6, left). We saw at least one of
these classes. CG3066 mutant ﬂies live longer than do wild-
type ﬂies infected with S. pneumoniae and are better at clearing
the infection because they have a heightened resistance
response. In this case we suggest that when melanization
occurs, ﬂies are less able to defend themselves against the
infection; perhaps the ﬂies waste energy on a nonproductive
immune response or suffer from autoimmune damage.
CG3066 ﬂies infected with E. faecalis provides a second special
case, where we can determine changes in resistance and
tolerance; the survival rate of CG3066 mutants and wild-type
parental strains were the same. This means that resistance
and tolerance changes must be balanced, and we conclude
that since resistance is increased in these ﬂies, tolerance must
have decreased.
We showed that CG3066 is important in controlling the
nature of the infection. In the case of L. monocytogenes,w e
found that there are more extracellular bacteria present in
CG3066 mutants while the number of intracellular microbes
remains constant. We suggest two mechanistic explanations
for this change in the nature of the infection. First,
melanization may be responsible for killing extracellular L.
monocytogenes, and a loss in CG3066 results in an increase in
extracellular bacteria. Second, CG3066 might be responsible
for killing ﬂy cells infected with L. monocytogenes, and if this
does not happen, the cells may release larger numbers of
bacteria into the circulation.
We made assumptions about the shape of tolerance curves
when interpreting our data. We determined the life span of
uninfected ﬂies and compared this to the lifespan of infected
ﬂies and measured their bacterial levels 24 h postinfection. If
these data were graphed, they would deﬁne two points and a
tolerance curve could be interpolated between them. We
interpreted our results as if the tolerance curve was a straight
Figure 6. Summary of Mutant Classes
We propose that resistance and tolerance can vary independently of each
other, resulting in nine phenotypic classes. Three of these classes are
clearly observable in CG3066 mutants when infected with E. faecalis, B.
cepacia,o rE. coli. Infections of CG3066 mutants fall into the class where
resistance is increased but changes in tolerance cannot be easily
measured here. Likewise, L. monocytogenes and S. typhimurium fall into
the class where resistance is decreased but tolerance cannot be measured.
doi:10.1371/journal.pbio.0060305.g006
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result in a decrease in survival. This is an assumption and
should apply to some infections; however, it is possible to
imagine alternative tolerance curves. We made this assump-
tion because we do not know the actual shape of any of these
curves and chose the simplest possibility. This raises the point
that to truly understand the nature of microbial pathogenesis
we will have to precisely deﬁne tolerance curves.
Resistance and tolerance are predicted to have very
different evolutionary outcomes [37]. For resistance, if the
beneﬁts of the trait outweigh the cost of the trait then the
number of hosts with that resistant trait will become more
frequent in a population. As the trait occurs in higher
proportions the occurrence of disease will decrease. Even-
tually the occurrence will become so low that the cost of the
trait then outweighs the beneﬁts of the trait and the trait will
cease spreading through a population. Therefore a resistance
trait is not predicted to become ﬁxed in a population. The
dynamics of a tolerance trait should be quite different. As a
tolerance trait spreads through a population the occurrence
of disease may also increase because more tolerant hosts are
available to infect. Because the incidence of disease remains
high the beneﬁts of carrying the tolerance trait will always
outweigh the costs of having it, so the tolerance trait is
predicted to become ﬁxed in a population. Our results have
very important implications for the evolutionary dynamics of
tolerance traits. We show that a tolerance trait can actually be
quite dynamic and predict that it will not reach ﬁxation
because the same trait can serve as a resistant trait for a
different pathogen. Furthermore, resistant traits are typically
highly dynamic because of the coevolutionary relationship
they have with pathogens, and this will feed into the system
with corresponding changes in tolerance. Our ﬁndings
suggest that the evolutionary dynamics of resistance and
tolerance can be highly ﬂuid even in the absence of pathogens
driving such genetic instability in a host.
We noted an interaction between wounding, survival, and
melanization; CG3066 mutant ﬂies that were given an injection
of sterile medium were shorter lived compared to wild-type
ﬂies given the same treatment. Unmanipulated CG3066 and
isogenic parental lines showed no difference in survival. We
have always found that medium-injected ﬂies die faster than
unmanipulated ﬂies and do not know the pathology behind
this early death. It remains possible that these ﬂies are
suffering from a cryptic infection of the native microbiota in
the ﬂy vial or that the wound healing process itself causes
some pathology. These results demonstrate that CG3066
contributes to a ﬂy’s ability to withstand this pathology.
An issue that arises as a result of the difference in the
survival rate of CG3066 ﬂies in medium-injected ﬂies versus
unmanipulated controls is that if the medium-injected
CG3066 ﬂies die faster than do wild-type ﬂies, how can we
determine which ﬂies have changes in immunity? We have
two answers to this question: The ﬁrst is that in the three
cases where we see CG3066 ﬂies dying faster than wild-type
ﬂies during an infection, we found that this is associated with
an increased growth of bacteria and conclude that these ﬂies
have a resistance defect, in addition to other problems that
they might have. The second answer is that we suggest the
ﬂies are dying for different reasons in medium-injected
versus pathogen-infected ﬂies, and that the two processes do
not necessarily correlate with each other. We do not know the
cause of pathology in either death by infection or death by
wounding and have no reason to suspect that they are
identical.
Recent studies suggested that these immune mechanisms
are dispensable in Drosophila with respect to their importance
for survival to microbial infections or, at best, serve a
redundant role [24,25]. These experiments were carried out
by assaying the phenotypes of CG3066 mutants. We are
careful to limit the analysis of our phenotypes to the effects
of CG3066 and do not go so far as to state that the loss of
melanization is the cause for the phenotypes we observe. It
remains possible that CG3066 serves additional roles in ﬂy
immunity and does not solely activate phenoloxidase. Here
we report that the response initiated by CG3066 is important
for surviving infections and that its effects are dependent on
the type of infection. This response affects both resistance
and tolerance mechanisms in Drosophila. We suggest that the
importance of these mechanisms was missed previously
because past studies utilized microbes that do not induce a
strong melanization response in the ﬂy, did not measure
bacterial loads in the infected ﬂies, did not take the survival
curves out to completion, and compared mutants to other
mutants instead of to wild-type ﬂies.
The ﬁndings reported here have implications about the
evolution of immunity; they suggest that polymorphisms that
increase resistance to one pathogen may reduce the
resistance or tolerance to other pathogens and thus the
defense response of a given ﬂy strain will likely be optimized
by its interaction with microbes in the wild. As a result, there
is likely no ‘‘best’’ solution that produces a perfect immune
system, only an equilibrium that allows the ﬂy to survive the
pathogenic threats that its ancestors have faced. This
equilibrium will require the balancing of both resistance
and tolerance, and thus we can not completely understand
the defensive properties of a host unless we measure both of
these properties in response to a variety of pathogens.
Materials and Methods
Fly strains. The wild-type parental strain used in all experiments is
white
1118 (Bloomington stock center, stock 6326) The CG3066
KG02818
allele was obtained from Bloomington stock center and backcrossed
onto the white
1118 background for four generations. Flies were kept in
standard ﬂy bottles containing dextrose medium.
Bacterial strains. All strains used are listed in Table 1.
Pathogen culture conditions. S. pneumoniae cultures were grown
standing at 37 8C5 %C O 2 in brain heart infusion medium (BHI) to an
OD600 of 0.15 and aliquots were frozen at 80 8C in 10% glycerol. For
infection, an aliquot of S. pneumoniae was thawed and diluted 1:3 with
fresh BHI medium and allowed to grow to OD600 of 0.15 at 37 8C5 %
CO2. Bacteria was then concentrated to an OD600 of 0.3 in PBS. E. coli,
E. faecalis, and S. typhimurium cultures were grown overnight at 37 8Ci n
Luria Bertani (LB) medium. E. coli and E. faecalis cultures were shaken,
while S. typhimurium cultures were grown standing. E. coli and S.
typhimurium cultures were diluted to OD600 of 0.1 with fresh LB
medium prior to injection. E. faecalis cultures were diluted to an
OD600 of 0.05 with medium. B. cepacia cultures were grown standing
overnight in LB medium at 29 8C and injected at an OD600 of 0.001. L.
monocytogenes and S. aureus were grown in BHI medium. L. monocytogenes
was grown standing and injected at an OD600 of 0.01. S. aureus was
grown shaken and injected at an OD600 0.001.
Injections. Male 5- to 7-d-old ﬁles were used for injection. Flies
were anesthetized with CO2 and injected with 50 nl of culture using a
picospritzer and pulled glass needle. Flies were injected in the
anterior abdomen on the ventrolateral surface. Flies were then placed
in vials containing dextrose medium in groups of twenty and
incubated at 29 8C, 65% humidity with the exception of B. cepacia,
which was incubated at 18 8C with no humidity control.
Survival curves. For each microbe tested, w
1118 and CG3066
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were placed in dextrose vials in groups of 20 after injection and a
total of sixty ﬂies were assayed for each condition. The number of
dead ﬂies was counted daily. Using Prism software, Kaplan-Meier
survival curves were generated and statistical analysis was done using
log-rank analysis. Survival was tested for each microbe listed in Table
1 at least three times and gave similar results for each trial.
CFU determination and gentamicin chase. Infected ﬂies were
homogenized in media supplemented with 1% Triton X-100 and
serially diluted. S. pneumoniae-infected ﬂies were homogenized in PBS
without triton. Dilutions were plated on LB agar plates (blood agar
plates for S. pneumoniae) and incubated overnight. The data was
plotted as box-and-whisker plots using Graphpad Prism software for
three independent experiments. The p-value was determined with a
nonparametric two-tailed t-test. For the gentamicin chase experi-
ments, ﬂies were injected with 50 nl of 1 mg/ml gentamicin or water 3
h prior to homogenizing and plating.
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